Pursley James 4
4 · Hinge Health, Inc. · Filed Feb 24, 2026
Research Summary
AI-generated summary of this filing
Hinge Health (HNGE) President James Pursley Sells Shares
What Happened
James Pursley, President of Hinge Health (HNGE), sold a total of 15,000 shares in open-market transactions on February 23, 2026 for aggregate proceeds of approximately $589,984. The sales were reported as three dispositions: 7,874 shares at an average around $38.76 ($305,159), 6,818 shares at an average around $39.95 ($272,363), and 308 shares at about $40.46 ($12,462). These were sales (not purchases or option exercises) and were effected under a pre-established trading plan.
Key Details
- Transaction date: February 23, 2026; Form 4 filed February 24, 2026 (timely filing).
- Shares sold: 7,874; 6,818; 308 — total 15,000 shares.
- Proceeds: $305,159; $272,363; $12,462 — total ≈ $589,984.
- Price details / footnotes:
- F1: Sales executed pursuant to a Rule 10b5-1 trading plan adopted June 12, 2025.
- F2–F4: Weighted-average prices reported for each line; reported lowest/highest sale prices in the ranges were $38.435–$39.41, $39.45–$40.44, and $40.45–$40.46 respectively. The filer offers to provide per-price share counts on request.
- Shares owned after transaction: Not specified in the provided filing.
Context
- Sales under a 10b5-1 plan are typically pre-scheduled and are common for insiders to diversify or meet liquidity needs; they are not necessarily an indicator of new negative sentiment.
- This filing reports outright sales (code S); no option exercises, grants, or gifts are involved.
- For retail investors, purchases are usually more informative than routine sales; note these were disposals under a pre-set plan.
Insider Transaction Report
Form 4
Pursley James
President
Transactions
- Sale
Class A Common Stock
[F1][F2]2026-02-23$38.76/sh−7,874$305,159→ 759,357 total - Sale
Class A Common Stock
[F1][F3]2026-02-23$39.95/sh−6,818$272,363→ 752,539 total - Sale
Class A Common Stock
[F1][F4]2026-02-23$40.46/sh−308$12,462→ 752,231 total
Footnotes (4)
- [F1]The sales reported in this line item were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 12, 2025.
- [F2]Represents the weighted average sale price. The lowest price at which shares were sold was $38.435 and the highest price at which shares were sold was $39.41. The Reporting Person undertakes to provide upon request to the staff of the Securities and Exchange Commission, the Issuer or its stockholders, full information regarding the total number of shares sold at each separate price within the range set forth herein.
- [F3]Represents the weighted average sale price. The lowest price at which shares were sold was $39.45 and the highest price at which shares were sold was $40.44. The Reporting Person undertakes to provide upon request to the staff of the Securities and Exchange Commission, the Issuer or its stockholders, full information regarding the total number of shares sold at each separate price within the range set forth herein.
- [F4]Represents the weighted average sale price. The lowest price at which shares were sold was $40.45 and the highest price at which shares were sold was $40.46. The Reporting Person undertakes to provide upon request to the staff of the Securities and Exchange Commission, the Issuer or its stockholders, full information regarding the total number of shares sold at each separate price within the range set forth herein.
Signature
/s/ James Budge, Attorney-in-Fact|2026-02-24